The COVID-19 Pandemic as a Public Health Teacher—the Lessons We Must Learn

Since 5th May 2023 COVID-19 is not considered a Public Health Emergency of International Concern (PHEIC), rather “an established and ongoing health issue” [1]. This was a moment to celebrate achievements, like the dedication of healthcare workers but also to reflect on the mistakes made [1]. Many COVID-19 deaths are still reported to the World…

The use of healthcare services and disabling chronic pain: results from the cross-sectional population-based Andalusian Health Survey

Background Several factors seem to be related to the use of healthcare services, and chronic pain (CP) is among these characteristics. The objective is to describe the number of visits to a doctor’s surgery or emergency rooms, and the periods of hospitalization; to identify characteristics associated with frequent healthcare use, including disabling chronic pain (DCP)…

Jornada Comités ética

#ÉticaInvestigaciónSSPAOrganiza: Secretaría General de Salud Pública e I+D+I en Salud. Consejería de Salud y Consumo. Comité Coordinador de Ética de la Investigación Biomédica de Andalucía, con la colaboración de Escuela Andaluza de Salud Pública. Fecha: 6 y 7 de junio de 2024. Lugar de celebración: Escuela Andaluza de Salud Pública. Coordinación científica – Mariano Aguayo…

Jornada Cáncer cabeza y cuello

#CáncerCabeza-CuelloJornada PRESENCIAL Y VIRTUAL Derivación temprana y Detección Precoz del Cáncer de Cabeza y Cuello en Andalucía   Coordinación Científica Dr. Antonio Rueda Domínguez. Jefe de Servicio de Oncología Médica. Hospital Regional Universitario de Málaga. Dra. Maria José Sánchez Pérez. Profesora de la Escuela Andaluza de Salud Pública. Directora del Registro de Cáncer de Granada.…

Long-term survival for lymphoid neoplasms and national health expenditure (EUROCARE-6): a retrospective, population-based study

Background Management of lymphoid malignancies requires substantial health system resources. Total national health expenditure might influence population-based lymphoid malignancy survival. We studied the long-term survival of patients with 12 lymphoid malignancy types and examined whether different levels of national health expenditure might explain differences in lymphoid malignancy prognosis between European countries and regions. Methods For…